P. Lampropoulou

Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma

M. Dimopoulos, M. Angelopoulou, G. Pangalis, 2022, In Vivo.

Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes.

A. Symeonidis, G. Sakellaropoulos, E. Solomou, 2015, Cardiovascular & hematological disorders drug targets.

Hepatitis C in patients with β-thalassemia major. A single-centre experience

G. Kagadis, K. Thomopoulos, C. Triantos, 2013, Annals of Hematology.

Increased RANKL and IL-6 levels might result in high bone turnover in a case of a CD34+/CD117+/myeloperoxidase(+dim) acute myeloid leukemia presenting with severe hypercalcemia and lumbar spine fractures.

V. Zolota, A. Symeonidis, N. Giannakoulas, 2011, Leukemia research.